COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,159 Articles (22,703 medRxiv, 8,456 bioRxiv)

Most recent first Previous |  Page 1457: Articles 14561-14570  | Next

Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Horby, P. W., Pessoa-Amorim, G., Staplin, N., Emberson, J. R., Spata, E., Campbell, M., Peto, L., Brunskill, N., Tiberi, S., Chew, V., Brown, T., Tahir, H., Ebert, B., Chadwick, D. R., Whitehouse, T., Sarkar, R., Graham, J. C., Baillie, J. K., Basnyat, B., Buch, M. H., Chappell, L. C., Day, J. N., Faust, S. N., Hamers, R., Jaki, T., Jeffery, K., Juszczak, E., Lim, W. S., Montgomery, A., Mumford, A., Rowan, K., Thwaites, G., Mafham, M., Haynes, R., Landray, M. J.
10.1101/2021.06.08.21258132 — Posted: 2021-06-08 Discussion: Onsite
Targeting of Protein Kinase CK2 Elicits Antiviral Activity on Bovine Coronavirus Infection
Ramon, A. C., Perez, G. V., Caballero, E., Rosales, M., Aguilar, D., Vazquez-Blomquist, D. M., Ramos, Y., Rodriguez, A., Falcon, V., Rodriguez, M. P., Ke, Y., Perera, Y., Perea, S. E.
10.1101/2021.06.08.447588 — Posted: 2021-06-08
Predicted Coronavirus Nsp5 Protease Cleavage Sites in the Human Proteome: A Resource for SARS-CoV-2 Research
Scott, B. M., Lacasse, V., Blom, D. G., Tonner, P. D., Blom, N. S.
10.1101/2021.06.08.447224 — Posted: 2021-06-08
Single domain shark VNAR antibodies neutralize SARS-CoV-2 infection in vitro
Gauhar, A., Privezentzev, C. V., Demydchuk, M., Gerlza, T., Rieger, J., Kungl, A. J., Walsh, F. S., Rutkowski, J. L., Stocki, P.
10.1101/2021.06.08.447530 — Posted: 2021-06-08
ROS/RNS balancing, aerobic fermentation regulation and cell cycle control a complex early trait ('CoV-MAC-TED') for combating SARS-CoV-2-induced cell reprogramming
Costa, J. H., Mohanapriya, G., Revuru, B., Noceda, C., Thiers, K. L. L., Aziz, S., Srivatsava, S., Oliveira, M., Gupta, K. J., Kumari, A., Sircar, D., Kumar, S. R., Achra, A., Sathishkumar, R., Adhloeya, A., Arnholdt-Schmitt, B.
10.1101/2021.06.08.447491 — Posted: 2021-06-08
In depth analysis of Cyprus-specific mutations of SARS-CoV-2 strains using computational approaches
Oulas, A., Richter, J., Zanti, M., Tomazou, M., Michailidou, K., Christodoulou, K., Christodoulou, C., Spyrou, G. M.
10.1101/2021.06.08.447477 — Posted: 2021-06-08
FXa cleaves the SARS-CoV-2 spike protein and blocks cell entry to protect against infection with inferior effects in B.1.1.7 variant
Yu, J., Dong, W., Wang, J., Tian, L., Zhang, J., Mead, H. L., Jaramillo, S., Li, A., Zumwalt, R., Whelan, S. P. J., Settles, E., Keim, P., Barker, B. M., Caligiuri, M.
10.1101/2021.06.07.447437 — Posted: 2021-06-08
Mapping Potential Antigenic Drift Sites (PADS) on SARS-CoV-2 Spike in Continuous Epitope-Paratope Space
Miller, N. L., Clark, T., Raman, R., Sasisekharan, R.
10.1101/2021.06.07.446560 — Posted: 2021-06-08
The UK Coronavirus Job Retention Scheme and changes in diet, physical activity and sleep during the COVID-19 pandemic: Evidence from eight longitudinal studies
Wielgoszewska, B., Maddock, J., Green, M. J., Di Gessa, G., Parsons, S., Griffith, G. J., Croft, J., Stevenson, A. J., Booth, C., Silverwood, R. J., Bann, D., Patalay, P., Hughes, A. D., Chaturvedi, N., Howe, L. D., Fitzsimons, E., Katikireddi, S. V., Ploubidis, G. B.
10.1101/2021.06.08.21258531 — Posted: 2021-06-08
Seroprevalence of SARS-CoV-2 Antibodies Among Rural Healthcare Workers
Neises, J. Z., Saddam, H. M., Sultana, R., Wanniarachchi, K. N., Wollman, J. W., Nelson, E., Specker, B. L., Hoppe, A. D., Lawson, S. R., Thiex, N. W.
10.1101/2021.06.07.21258375 — Posted: 2021-06-08

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).